Yayınlar

PROF.DR.ERKAN TOPUZ’UN
YAYINLARINDAN BAZILARI
ULUSLARARASI MAKALELER

 

 

 

  • Topuz E., Töre G., Kural N., Aldemir O., Kınay M., Dinçol K., Güzel Ö.:
Der Wert der Neuraminsaure als klinischer Parameter bei 42 Patienten mit kleinzelligem Bronchialkarzinom.
Strahlentherapie und Onkologie, 162: 613-617, 1986.
  • Topuz E., Töre G., Bilge N., Aldemir O., Kural N., Kınay M., Güzel Ö.:
Neuraminsaure (NANA) im Serum als Indikator beim Mammakarzinom.
Strahlentherapie und Onkologie 162: 187-190, 1986.
  • Töre G., Aldemir O., Topuz E., Kuter S.,Aslay I., Kural N., Kınay M.:
Elektronenbestrahlung des Kollumkarzinoms mit einem neunen transvaginalen
Tubussystem das am Betatron angesetzt wird.
Strahlentherapie und Onkologie, 162: 455-458, 1986.
  • Topuz E., Aldemir O., Töre G., Bilge N., Kural N.:
Die Ergebnisse der Strahlentherapie und Chemotherapie beim kleinzelligen Bronchialkarzinom
Strahlentherapie und Onkologie, 162: 17-19, 1986.
  • re G., Topuz E., Bilge N., Aslay I., Dinçer M., Elgin E.:
The role of adjuvant chemotherapy in the treatment of uterine sarcoma patients.
Eur.J.Gynaec.Oncol. 11:1990)
  • Topuz E., Zissis N.P., Dinçer M., Oral E.N.:
Intraperitoneal instillation of mitoxantrone in the treatment of malignant pleural effusions.
Regional Cancer Treatment. 3: 323-325, 1991.
  • Rıdvanoğulları M., Aydıner A., Anıl D., Sayın U., Dinçol K., Topuz E.,
Aykan N.:
Potentiation of etoposide-induced DNA damage by verapamil in L-starin cells in vitro.
J.Exp.Clin.Cancer Res. 4:255-260, 1993.
  • Aydıner A., Onat H., Öztürk N., Aykan F., İnanç S.E., Topuz E., K.Dinçol.:
The Efficacy of a Five-Drug Antiemetic Combination During Chemotherapy Regimens Containing Cisplatin or Cyclophosphamide-       “Doxorubicin.
Journal of Pain and Symptom Management. 8: 126-131, 1993.
  • Topuz E., Aydıner A., Kizir A., Kardaş H., Öztürk N., Oral E.N., Dinçer M.:
Local and Systemic Complications Associated with Intraperitoneal Chemotherapy.
Regional Cancer Treatment. 4:218-222, 1994
  • Aydıner A.,Topuz E., Dişçi R., Yasasever V., Dinçer M., Dinçol K., Bilge .:
Serum Tumor Merkers For Detection of Bone Metastases in Breast Cancer Patients.
Acta Oncologica, 33: 181-186, 1994.
  • Aydıner A., Buğra Z., Topuz E., Meriç M.:
Acute Myocardial Infarction in Man Treated with Epirubicin for Non- Hodgkin Lymphoma
American Journal of Clinical Oncology, 18(5): 444-448, 1995.
  • Onat H., İnanç S., Saip P., Topuz E.:
Preventation of chemotherapy-induced emesis in patients with germ cell tumors receiving multiple-day cisplatin-based chemotherapy: efficacy and tolerability of tropisetron.
Turkish Journal of Cancer, 26:4:1996.
  • Aydıner A., Aytekin Y., Topuz E.:
Effects of Cisplatin on Testicular Tissue and the Leydig Cell-Pituitary
Axis.
International Journal of Cancer Research and Treatment, ONCOLOGY, 54: 74-78, 1997.
  • Yasasever V., Dinçer M., Çamlıca H., Karaloğlu D., Kizir A., Topuz E.,
Dalay N.:
CYFRA 21-1 is the Most Sensitive Tumor Marker in Non-Small Cell Lung
Cancer.
Journal of Tumor Marker Oncology. 12: 2: 135-140, 1997.
  • Aydıner A., Rıdvanoğulları M., Anıl D., Topuz E., Nurten R., Dişçi R.:
Combined effects of epirubicin and tamoxifen on the cell-cycle phases
in estrogen-receptor-negative Ehrlich ascites tumor cells.
J Cancer Res Clin Oncol, 123: 2: 113-117, 1997.
  • Topuz E., Aydıner A., Saip P., Bengisu E., Berkman S., Dişçi R.:
Intraperitoneal cisplatin-mitoxantrone in ovarian cancer patients with       minimal residual disease
Eur. J. Gynaec. Oncol. 18: 1: 71-75, 1997
  • Saip P., Onat H., İnanç S., Topuz E., Dişçi R.:
The effect of ondansetron and domperidon as antiemetics in breast cancer
patients receiving cyclophosphamide, epirubicin and fluorouracil during three
subsequent courses.
Turkish Journal of Cancer, 27: 1: 1997.
  • Topuz E, Saip P, Aydıner A, Salihoğlu Y, Yılmaz T, Topuzlu C.:
Catheter complications associated with intraperitoneal chemotherapy.
Eur J Gynaec Oncol 19: 3: 275-279, 1998.
  • Topuz E, Saip P, Aydıner A, Salihoğlu Y, Berkman S, Bengisu E.:
Intraperitoneal cisplatin-mitoxantrone and intravenous ifosfamide combination as first-line treatment of ovarian cancer.
Eur J Gynaec Oncol 19: 3: 265-270, 1998.
  • Saip P., Yasasever V., Tenekeci N., Aydıner A., İnanç S., Onat H., Dişçi R.,
Topuz E.:
Prediction of radiological response of bone metastases to therapy by biochemical marker monitoring in patients with breast cancer: A preliminary Study.
Journal of Tumor Marker Oncology 13: 3: 45-52, 1998.
  • Topuz E., Aydıner A., Eralp Y., Uygun K., Saip P., Taş F.:
Preliminary Results of a Phase II Study with Mitomycin-C Vinorelbine for the
Treatment of Metastatic Breast Cancer
American Society of Clinical Oncology, Thirty-Fifth Annual Meeting, May
15-18,1999 Atlanta, GA
  • . Aydıner A.,Karadeniz A., Uygun K., Taş Ş., Dişci R., Topuz E.:
Differences Between Synchronous and Metachronous Multiple Primary
Neoplasms
American Society of Clinical Oncology, Thirty-Fifth Annual Meeting, May
15-18,1999 Atlanta, GA
  • Oral EN., Bavbek ES., Kizir A., Yöney A., Yaman F., Darendeliler ME.,
Topuz E.:
Preliminary Results of Weekly Parlitaxel (P) and Continuous
Hyperfractionated Accelerated Radiotherapy (CHART) in Locally Advanced
Non-Small Cell Lung Cancer (NSCLC)
American Society of Clinical Oncology, Thirty-Fifth Annual Meeting, May
15-18,1999 Atlanta, GA
  • Salepçi T., Yazıcı H., Topuz E., Dalay N.,Onat H., Aykan NF., Aydıner A.;
Detection of Human Papillomavirus (HPV) DNA ,n Human Colorectal
Cancers By Polymerase Chain Reaction (PCR)
American Society of Clinical Oncology, Thirty-Fifth Annual Meeting, May
15-18,1999 Atlanta, GA
  • Saip P., Tenekeci N., Aydıner A., Dinçer M., İnanç S., Demir C., E.N.Oral.,
Topuz E.:
Response Evaluation of Bone Metastates in Breast Cancer: Value of Magnetic
Resonance Imaging.
Cancer Investigation, 17(8), 575-580 1999
  • Oral E.N., Kaytan E., Karadeniz A., Kizir A., Aykan F., Dişçi R., Çamlıca H.,
Topuz E.:
Outcome of postperative adjuvant treatment and prognostic factors in rectal
Journal of BUON 4: 261-267,July-September 1999
  • Oral E.N., Bavbek S., Kizir A., Tenekeci N., Yöney A., Kaytan E., Topuz E.:
Preliminary analysis of a phase II study of Paclitaxel and CHART in locally
advanced non-small cell lung cancer.
Lung Cancer 25 (1999) 191-198
  • Tas F, Aydiner A, Topuz E, Camlica H, Saip P, Eralp Y.
Factors influencing the distrubition of metastases and survival in extensive disease small cell lung cancer.
Acta Oncol 38(8): 1011-1015, 1999
  • Taş F., Aykan N. F., Aydıner A., Uygun K., Başaran M., Çamlıca H., Topuz E.
The Roles of Chemotherapy and surgery in Gastric Carcinoma and the Influence of Prognostic Factotrs on Survival.
Am J Clin Oncol (CCT) 23 (1): 53-57,2000
  • E. Topuz, A. Aydıner, P. Saip, Y. Eralp, F. Taş, Y. Salihoğlu, N. Tenekeci.
Correlation of CA 125 Levels and Computerized Tomography Imaging with Laparotomic Findings Follwing Intraperitoneal Chemotherapy in Patients with Ovarian Cancer.
American Society of Clinical Oncology. Thirty-Sixth Annual Meeting May 20-23,2000.
  • A. Aydıner, A. Karadeniz, F. Yaman, K. Uygun, S. Taş, R. Dişçi, E. Topuz.
Risk Factors of for the Development of Second Primary Cancer (SPC) in Upper-Aerodigestive Cancer (UADC).
American Society of Clinical Oncology. Thirty-Sixth Annual Meeting May 20-23,2000.
  • Erkan Topuz, Yavuz Salihoğlu, Adnan Aydıner, Pınar Saip, Faruk Taş, Tamer Sözen,
Sinan Berkman, Ergin Bengisu.
Celsite Port and Catheter as an Intraperitoneal Access Device in the Treatment of Ovarian Cancer.
Journal of Surgical Oncology. Volume 74, Number 3, July 2000.
  • Aydıner A., Karadeniz A., Uygun K., Taş F., Dişçi R., Topuz E.
Multiple primary neoplasms at a single Institute: differences between synchronous and metachronous neoplasms. Am J Clin Oncol, 23: 364-70,2000
  • Topuz E., Aydıner A., Saip P., Eralp Y., Taş F., Salihoğlu Y., Tenekeci N.
Correlation of Serum Ca 125 Levels and Computerized Tomography (Ct) İmaging with Laparotomic Findings Following Intraperitoneal Chemotherapy in Patients with Ovarian Cancer. Eur J Gynecol Onco 599-602l, 2000
  • Topuz E., Eralp Y., Saip P., Aydıner A., Taş F., Salihoğlu Y., Berkman S., Bengisu E.
The effiacy of a Combination Chemotherapy Including Intraperitoneal Cisplatinum and Mitoxantrone with Intravenous Ifosfamide in Patients With FIGO stage I C Ovarian Carcinoma. Eur J Gynecol Oncol, 2000
  • Eralp Y., Aydıner A., Taş F., Saip P., Topuz E.
Stevens-Johnson Syndome in a Patient Receiving Anticonvulsant Therapy During Cranial Irradiation. Am J Clin Oncol, 2000
  • Taş F., Yavuz E., Aydıner A., Saip P., Dişçi R., İplikçi A., Topuz E.
Angiogenesis and p53 protein expression in breast cancer: their prognostic roles and interrelationships. Am J Clin Oncol, 2000
  • Taş F., Aykan NF., Aydıner A., Yasasever V., Topuz E.
The measurement of CA 19.9 may be more valuable than CEA in predictin of recurrence in gastric cabcer patients. Am j Clin Oncol, 2000
  • Taş F., Aydıner A., Topuz E., Yasasever V., Karadeniz A., Saip P.,
Utility of the serum tumor markers: Cyfra 21.1, carcinoembrynic antigen (CEA), and   squmous cell carcinoma antigen (SCC) in squamous cell lung cancer.                                         J Exp Clin Cancer
Res, 2000
  • Taş F.,Aydıner A., Yasasever V., Dişçi r., Topuz E.
Clinical usefulness of serum assays of carcinoembryonic antigen and beta 2- . . … microglobulin in the diagnosis and discrimination of metastasis of lung cancer. Tur J Cancer, 2000
  • Aydıner A., Koyuncu H., Tas F., Topuz E., Dişçi R.
Crossover Clinical Study Comparing The Pharmacokinetics of Etoposide (75 Mg) Administered As 25-Mg Capsules Three Times Aday Versus Once A Day. Clin Pharmacol Res, 2000
  • Tas F, Aydiner A, Demir C, Topuz E. ?
Serum lactate dehydrogenase levels at presentation predict outcome of patients with limited .stage small cell lung cancer.
Am J Clin Oncol, 24(4): 376-378, 2001
  • Topuz E, Salihoglu Y, Aydiner A, Saip P, Tas F, Sozen T, Berkman S, Bengisu E.
Celsite port and catheter as an intraperitoneal access device in the treatment of ovarian cancer.
J Surg Oncol 74: 223-226, 2000
  • Tas F, Aykan NF, Aydiner A, Uygun K, Basaran M, Camlica H, Topuz E.
The roles of chemotherapy and surgery in gastric carcinoma and the influence of prognostic factors on survival.
Am J Clin Oncol 23(1): 53-57, 2000
  • Tas F., Basaran M., Aydiner A., Eralp Y., Topuz E.
5- Fluorouracil induced balanitis in a patient with oesophageal carcinoma.
Clin Oncol, 13 (3): 170-171, 2001.
  • Eralp Y., Aydiner A., Tas F., Saip P., Topuz E.
Stevens – Johnson Syndrome in a patient receiving anticonvulsant therapy during cranial irradiation.     Am J Clin Oncol, 24 (4): 376-378, 2001.
  • Tas F., Aykan F., Alici S., Kaytan E., Aydiner A., Topuz E.
Prognostic factors in pantreatic carcinoma: serum LDH levels predict survival in metastatic disease.
Am J. Clin Oncol, 24 (6): 547-550, 2001.
  • Topuz E., Eralp Y., Aydiner A., Saip P., Tas F., Yavuz E., Salihoğlu Y.
The role of chemotherapy in malignant mixed mullerian tumors of the female genital tract.
Eur J Gynaecol Oncol, 22 (6): 469-472, 2001.
  • Tas F, Aydiner A, Tenekeci N, Karadeniz A, Sakar B, Topuz E.
Hyperthrophic osteoarthropathy associated with docetaxel treatment.
Clin Oncol, 13(2): 145-146, 2001
  • Tas F, Aykan NF, Aydiner A, Yasasever V, Topuz E.
Measurement of serum CA 19-9 may be more valuable than CEA in prediction of
recurrence in patients with gastric cancer.
Am J Clin Oncol, 24(2): 148-149, 2001
  • Argon A, Aydiner A, Tas F, Saip P, Topuz E.
Safety of paclitaxel in a patient with ovarian cancer and hyperbilirubinemia due to Rotor's
syndrome. Gynecol Oncol 85(2): 362- 364, 2002
  • Tas F, Eralp Y, Basaran M, Sakar B, Alici S, Argon A, Bulutlar G, Camlica H, Aydiner .        A, Topuz E.
Anemia in oncology practice: relation to diseases and their therapies.
Am J Clin Oncol, 25(4): 371-379, 2002
  • Topuz E, Basaran M, Saip P, Aydiner A, Argon A, Sakar B, Tas F, Uygun K, Bugra D,
Aykan F. Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone,
5-fluorouracil, and calcium folinate in patients with gastric cancer. A phase II study.
Am J Clin Oncol, 25(6): 619-624, 2002
  • Tas F, Agan M, Tenekeci N, Topuz E.
Retrovesical soft tissue metastasis of malignant thymoma.
Am J Clin Oncol, in press (accepted in May 2, 2002)
  • Taş F, Yasasever V, Duranyildiz D, Camlica H, Ustuner Z, Aydiner A, Topuz E.
The clinical value of Protein S100 and Melanoma Inhibitory Activity (MIA) I
malignant melanoma. Am J Clin Oncol, in press (accepted in Oct 29, 2002)
  • Tas F, Camlica H, Kurul S, Aydiner A, Topuz E.
Combination chemotherapy with docetaxel and irinotecan in metastatic malignant
melanoma.Clin Oncol, in press (accepted in Dec 11, 2002)
  • Tas F, Ustuner Z, Buyukbabani N, Tenekeci N, Topuz E.
Massive and isolated metastases to spleen of uveal malignant melanoma.
Retina, in press (accepted in Dec 12, 2002)
  • B. Sakar, M. Basaran, A. Argon, S. Alici, Y. Eralp, E. KAytan, D. Buğra, F.N. Aykan,
E.Topuz.
The Link between local recurrence and survival in patients with primary rectal cancer.
American Society of Clinical Oncology My 18-21, 2002.
  • Süleyman Alıcı., Yeşim Eralp, Pınar Saip, Andaç Argon, Mert Basaran, Erkan Topuz
and Adnan Aydıner.
Clinical Characteristics of Gestational Trophoblastic Disease at A Single Institute.
Thoku J. Exp. Med., 2002, 197, 95-100.
  • E. Topuz, P. SAip, A. Aydıner, Y. Eralp, S. Tuzlalı, S. Berkman.
Intraperitoneal cisplatinum as consolidation treatment for ovarian carcinoma at pathologic complete remission following primary platinum-based chemotherapy.
American Society of Clinical Oncology My 18-21, 2002.
  • S. Alici, S.E. Bavbek, Y. Eralp, A. Argon, M. Başaran, A. Aydiner S. Tuzlalı,                                  
E.Topuz, H. Onat.
An atypical presantation of metastatic gestational choriocarcinoma with
maxillary sinus and subcutaneous involvement; report of a case with literature review.
Journal of BUON 7: 373-376, 2002
  • Tas F, Tuzlali S, Aydiner A, Saip P, Salihoglu Y, Iplikci A, Topuz E.
The prognostic role of nm23 gene expression in patients with ovarian cancer.
Am J Clin Oncol, 25(2): 164-167, 2002
  • Tas F, Agan M, Tenekeci N, Topuz E.
Retrovesical soft tissue metastasis of malignant thymoma.
Am J Clin Oncol, 26: 366-368, 2003
  • Eralp Y, Saip P, Sakar B, Tas F, Aydiner A, Topuz E.
Efficacy of cisplatin and cyclophosphamide combination for recurrent and metastatic carcinoma of the uterine cervix
Eur J Gynaecol Oncol, 24: 323-326
  • Tas F, Karagol H, Karadeniz A, Topuz E.
Phlebitis due to irinotecan.
Clin Oncol, 15: 167, 2003
  • Tas F, Camlica H, Kurul S, Aydiner A, Topuz E.
Combination chemotherapy with docetaxel and irinotecan in metastatic malignant
melanoma.
Clin Oncol, 15: 132-135, 2003
  • Alıcı S, Aykan NF, Sakar B, Bulutlar G, Kaytan E, Topuz E.
Colorectal Cancer in Young Patients: Characteristic and Outcome.
Tohoku J. Exp. Med.,2003, 199 (2), 85-93.
  • Eralp Y, saip P, Sakar B, Kucucuk S, Aydiner A, Dincer M, Aslay I,Topuz E.
Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix.
Int J Gynecol Cancer 2003, 13,497-504.
  • Eralp Y., Aydıner A., Kizir A., Kaytan E., Oral E. N., Topuz E.
Resectable thymoma: treatment outcome and prognostic factors in the late adolescent and adult age group.
ECCO 12 the European Cancer Conference. 21-25 September 2003. Copenhagen
  • Süleyman Alici, Pinar Saip, Yeşim Eralp, Adnan Aydiner, Erkan Topuz.
Oral Etoposide (VP16) in platinum- Resistant Epithelial Ovarian Cancer (EOC).
Am J Clin Oncol (CCT) 26 (4): 358-352, 2003.
  • A. Aydıner, E. Topuz, E.N.Oral, E. Kaytan, H. Karagöl, Y. Eralp, A. Kizir.
Concominant chemotherapy in locally advanced non-small cell lung cancer: A phase II clinicaltrial.
American Society of Clinical Oncology. May 31 – June 3, 2003
  • E. Topuz, E. Kaytan, P. Saip, Y. Eralp, K. Sönmezoğlu, A. Aydıner.
Comparative evaluation of diagnosing recurrent ovarian carcinoma with CA 125, PET and CT.
American Society of Clinical Oncology. May 31 – June 3, 2003
  • P. Saip, S. Tuzlalı, K. Demir, B. Şakar, E. Yavuz, S. Berkman, E. Bengisu, E. Topuz.
Value of glutathion-s transferase pi (GST pi) as a prognostic factor in epithelial ovarian carcinoma.
American Society of Clinical Oncology. May 31 – June 3, 2003
  • Uygun K, Aydiner A, Saip P, Basaran M, Tas F, Kocak Z, Dincer M, Topuz E.
Granulosa cell tumor of the ovary: retrospective analysis of 45 cases.
Am J Clin Oncol, 26(5): 517-521, 2003
  • Erkan Topuz, Yesim Eralp, Sezer saglam, Pinar Saip, Adnan Aydiner, Sinan .   .       Berkman, Ekrem Yavuz.
Efficacy of intraperitoneal cisplatin as consolidation therapy in patients with pathologic
complete remission follwing front-line therapy for epithelial ovarian cancer.
Consolidative intraperitoneal cisplatin in ovarian cancer.
Gynecologic Oncology 92 (2004) 147-151.
  • P. Saip, H. Yazıcı, H. Karagöl, E. Bengisu, E. Topuz, N. Dalay.
Clinical features and prognosis of Turkish epithelial ovarian cancer patients with  BRCA1 and BRCA2 mutations.
American Society of Clinical Oncology. June 5-8, 2004.
  • A. Aydiner, E. Topuz, Y. Eralp, E. Kaytan, E.N. Oral, A. Kizir.
Induction chemotherapy with carboplatin and weekly paclitaxel followed by
Concominant chemoradiation in locally advanced non-small cell lung cancer.
American Society of Clinical Oncology. June 5-8, 2004.
  • Tas F, Duranyildiz D, Argon A, Oguz H, Camlica H, Yasasever V, Topuz E.
Serum bcl-2 and survivin levels in melanoma.
Melanoma Res, 14(6): 543-546, 2004
  • Tas F, Demir C, Camlica H, Ustuner Z, Topuz E.
Second-line docetaxel and gemcitabine combination chemotherapy in patients  with  non-small-cell lung cancer previously treated with platinum-based chemotherapy:a phase II trial.
Med Oncol, 21: 233-240, 2004
  • Taş F, Yasasever V, Duranyildiz D, Camlica H, Ustuner Z, Aydiner A, Topuz E.
The clinical value of Protein S100 and Melanoma Inhibitory Activity (MIA) in malignant
Melanoma. Am J Clin Oncol, 27: 225-228, 2004)
  • Tas F, Ustuner Z, Buyukbabani N, Tenekeci N, Topuz E.
Massive and isolated metastases to spleen of uveal malignant melanoma.
Retina, 24: 170-172, 2004
  • Tas F, Argon A, Camlica H, Topuz E.
Temozolomide in combination with cisplatin in patients with metastatic melanoma: a          .         phase II trial.
Melanoma Res , 2005 Dec; 15(6): 542-8.
  • Tas F, Duranyildiz D, Argon A, Oguz H, Camlica H, Yasasever V, Topuz E.
Serum levels of leptin and proinflammatory cytokines in advanced stage non-small cell      lung cancer. Med Oncol, 22(4): 353-358, 2005
  • Tas F, Oguz H, Argon A, Duranyildiz D, Camlica H, Yasasever V, Topuz E.
The value of serum levels of IL-6, TNF-alpha and erythropoietin in metastatic malignant
melanoma: serum IL-6 level is valuable prognostic factor at least as serum LDH in
advanced melanoma.
Med Oncol, 22(3): 241-246, 2005
  • Tas F, Duranyildiz D, Argon A, Oguz H, Camlica H, Yasasever V, Topuz E.
Apoptosis of lymphocytes in peripheral blood of patients with melanoma.
Med Oncol, 22(2): 177-182, 2005
  • Tas F, Duranyildiz D, Oguz H, Camlica H, Oral EN, Yasasever V, Topuz E.
The value of serum bcl-2 levels in advanced lung cancer patients.
Med Oncol, 22(2): 139-144, 2005
  • Tas F, Ustuner Z, Can G, Eralp Y, Camlica H, Basaran M, Karagol H, Sakar B, Disci R,
Topuz .E
The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients.
Acta Oncol, 44(2): 161-167, 2005
  • Tas F, Duranyildiz D, Oguz H, Disci R, Kurul S, Yasasever V, Topuz E.
Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in patients
with malignant melanoma.
Med Oncol, 22: 39-44, 2005
  • Tas F, Hansel H, Belce A, Ilvan S, Argon A, Camlica H, Topuz E.
Oxidative stress in breast cancer.
Med Oncol, 22: 11-16, 2005
  • Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E.
Serum vascular endothelial growth factor (VEGF) and Bcl-2 levels in advanced stage non- small cell lung cancer.
Cancer Invest, in press (accepted in Sep 22, 2005)
  • Tas F, Duranyildiz D, Oguz H,Camlica H, Yasasever V, Topuz E.
Serum vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) levels in small cell lung cancer.
Cancer Invest, in press (accepted in Sep 20, 2005)
  • Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E.
The value of serum Bcl-2 levels in advanced epithelial ovarian cancer.
Med Oncol , in press (accepted in Sep 12, 2005)
  • Tas F, Argon A, Disci R, Topuz E.
Pattern and outcome of admission to a medical oncology inpatient service.
J Cancer Edu, in press (accepted in May 17, 2005)
  • Tas F., Duranyıldız D., Oğuz H., V., Topuz E.
The value of serum bcl-2 levels in advanced epithelial ovarian cancer.
Medical Oncology, vol.23, no.2, 213-217,2006.
  • Faruk Taş, Derya Duranyıldız , Hilal Oğuz ,Hakan Çamlıca ,Vildan Yasasever and
Erkan Topuz.
Circulatin Serum levels of angiogenic factors and vascular endothelial growth    factor
receptors 1 and 2 in melanoma patients. Melanoma research 2006, Vol 16 No 5.
  • Faruk Tas.MD,Derya Duranyıldız,Ph.D,Hakan camlıca,M.D,Vildan Yasasever, Ph.D                and Erkan Topuz,M.D
Serum Vascular Endothelial Growth Factor (VEGF)and Bcl-2 Levels in Advanced
Stage Non –Small cell Lung Cancer Cancer Investigation, 24:576 – 580,2006
The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer.
Med Oncol. 2007;24(1):39-43.
Pattern and outcome of admission to a medical oncology inpatient service.
J Cancer Educ. 2007 Summer;22(2):80-5.
Topuz E.
Effect of maximum-tolerated doses and low-dose metronomic chemotherapy on serum
vascular endothelial growth factor and thrombospondin-1 levels in patients with  advanced non small cell lung cancer.
Cancer Chemother Pharmacol. 2007 Jun 7;
Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma.
Lung Cancer. 2007 Jul;57(1):79-83. Epub 2007 Mar 26.
  • Saip P., Çiçin İ., Eralp Y., Küçücük S., Tuzlalı S., Karagöl H., Aslay I., Topuz E.
Factors affecting the prognosis of breast cancer patients with brain metastases.  The Breast XX (2008) 1-8.
  • E. Topuz, D.Derin, G. Can, E. Kürklü, S. Çınar, F. Aykan, A. Çevikbaş, R. Dişçi, Z.
Durna, B. Şakar, S. Saglam, H. Tanrıyeri, G. Deniz, Ü. Gürer, F. Taş, N. Güney, A. Aydıner.
Effect of oral, administration of kefir on serum proinflammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancer.
Invest New Drugs (2008) 26: 567-572.
  • Y. Eralp, D. Derin, Y. Özlük, E. Yavuz, N. Güney, P. Saip, M. Müslümanoğlu, A. İğci, S. Küçücük, M. Dinçer, A. Aydıner, E. Topuz.
MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triplnegative breast cncer.
Annals of Oncology 19: 669-674, 2008.
  • Deligezer U, Eralp Y, Akisik EZ, Akisik EE, Saip P, Topuz E, Dalay N.
Effect of adjuvant chemotherapy on integrity of free serum DNA in patients with breast cancer. Ann N Y Acad Sci. 2008 Aug;1137:175-9
ULUSLARARASI BİLDİRİ ÖZETLERİ
  • Bilge N., Kınay M., Topuz E.:
The treatment of Ewing’s Sarcoma: A Retrospective Study of 74 Cases
Treated with and without Adjuvant Chemotherapy.
Vth European Congress of Radiology Iind Meeting of the ESTRO. Bordeaux
5-10 September 83. Abstracts Book. p.50 696(P)
  • Topuz E., Töre G., Bilge N., Kınay M., Aldemir O., Dinçol K.:
The effect of postopreative radiotherapy versus radiotherapy plus chemotherapy on treatment results.
Turkish-Arab Breast Cancer Symposium. Sheraton Hotel, İstanbul-Turkey.
16-17 May, 1983.
  • Topuz E., Töre G., Kınay M., Bilge N., Aldemir O.:
A new transvaginal cone for local electron radiation of cervical cancer.
3rd European Conference on Clinical Oncology and Cancer Nursing.
pp.121 abstracts book.458, Stockholm. June 16-20, 1985
  • Topuz E., Töre G., Kınay M., Bilge N., Aldemir O.:
NANA levels as a prognostic radicator in small cell lung cancer.
3rd European Conference on Clinical Oncology and Cancer Nursing.
pp.93 abstracts book.347, Stockholm. June 16-20, 1985
  • Kınay M., Bilge N., Topuz E., Dinçol K., Aldemir O., Töre G.:
Extramedullary plasmosytomas of the head and neck: 14 cases
3rd European Conference on Clinical Oncology and Cancer Nursing.
pp.198 abstracts book.769, Stockholm. June 16-20, 1985
  • Topuz E., Aldemir O., Töre G., Bilge N., Kınay M.:
The (5 year) results of a combination treatment method (CT+KT+CY) in the
small cell cancer of the lung.
3rd European Conference on Clinical Oncology and Cancer Nursing.
pp.100 abstracts book.373, Stockholm. June 16-20, 1985
  • Topuz E., Töre G., Dinçol K., Aldemir O., Kınay M.:
The Values of NSE, NANA and CEA as Tumour Markers in Lung           Cancer.
5th Annual Meeting of the European Society for Therapeutic Radiology and Oncology (ESTRO). Baden-Baden, Germany, 1986.
  • Töre G., Topuz E., Aldemir O., Dinçol K., Kınay M.:
Postoperative Irradiation vs. Postoperative Irradiation Plus Chemotherapy in Sarcomas.
5th Annual Meeting of the European Society for Therapeutic Radiology and Oncology (ESTRO). Baden-Baden, Germany, 1986.
  • Bilge N., Kınay M., Darendeliler E., Topuz E., Töre G., Aldemir O.:
Non-Hodgkin’s Lymphomas of Head and Neck: Extranodal Sites.
5th Annual Meeting of the European Society for Therapeutic Radiology and Oncology (ESTRO). Baden-Baden, Germany, 1986.
  • Onat H., İnceman S., Bilge N., Dinçol K., Töre G., Topuz E.:
Effect of Tamoxifen on Antithrombin III Activation in Breast Cancer      Patients.
15th International Congress of Chemotherapy, Istanbul, 1987
  • Topuz E., Topuzlu C., Töre G., Erkurt E.:
Postoperative Chemotherapy in the Advanced Undifferentiated Gastric  Carcinomas: An Optimistic View.
2nd Mediterranean Surgical Congress with International Participation.
Athens, 1989.
  • Aykan N.F., Bilge N., Onat H., Kınay M., Topuz E., Dinçol K., Necatioğlu B., Uzal C.:
Le Role De Prognostic Des Transfusions Sanguines Dans La Maladie De Hodgkin.
Biology of Human Malignant Lymphomas. Bordeaux- France, 1990.
  • Topuz E., Zissis N.P., Dinçer M., Oral E.N., Bilge N.:
Intrapleural Mitoxantrone in the Treatment of Malignant Pleural Effusions.
ECCO 6, Firenze, 1991.
  • Topuz E., Dinçer M., Oral E.N., Kardaş H., Yöney A., Zissis N.P.:
Intraperitoneal Chemotherapy (IPCT) in the Treatment of Gastrointestinal Cancers (GIS) and Liver Metastases.
ECCO 6, 1991.
  • Topuz E., Dinçer M., Oral E.N., Kardaş H., Töre G., Topuzlu C.:
Technical Aspects and Complications of Intraperitoneal Chemotherapy (IPCT) ECCO 6, 1991.
  • Topuz E.,Kizir A.,Oral E.N.,Kardaş H.,Dinçer M.,Öztürk N.,       C.Topuzlu.:
Intraperitoneal Chemotherapy in the Treatment of Primary and Metastatic Liver Cancers. International Conference on Biology and Treatment of Gastrointestinal Malignancies. Frankfurt-Main, Germany, 1992.
  • Topuz E., Kizir A., Oral E.N., Kardaş H., Dinçer M., Yöney A.:
Intraperitoneal Adjuvant Chemotherapy in the Treatment of
Gastrointestinal Cancers
International Conference on Biology and Treatment of Gastrointestinal Malignancies. Frankfurt-Main, Germany, 1992.
  • Altun M.,Topuz E.,Onat H.,Aldemir O.,Bilge N.,Darendeliler E.,Kınay M.:
Adjuvan Cisplatinum Based Chemotherapy For Loco-Regionally Advanced Undifferantiated Nasopharyngeal Carcinoma (UNC).
Interaction of Chemotherapy and Radiotherapy in Solid Tumors.
Genoa, Italy, 1992.
  • Topuz E., Öztürk N., Aydıner A., Kizir A., Kardaş H., Oral E.N.:
Intraperitoneal chemotherapy for primary and refractory ovarian cancer.
XVIIth Congress of the European Society for Medical Oncology, France. Annals of Oncology, 3 (supplement 5): 107, 1992.
  • Aydıner A.,Onat H.,Öztürk N.,Aykan F.,İnanç S.,Topuz E., Dinçol K.:
The efficacy of a five-drug antiemetic regimen on consequent cisplatin containing chemotherapies. XVIIth Congress of the European Society for Medical Oncology, France. Annals of Oncology, 3 (supp. 5): 187, 1992.
  • Onat H., Aydıner A., İnanç S., Dinçol K., Topuz E.:
Crossover trial of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Fourth International Congress on Anti-Cancer Chemotherapy, France. Abstract book, p.217, 1993.
  • Darendeliler E., Onat H., İnanç S.E., Kurul S., Erseven G., Aktan G.,      Riggi M., Topuz E., Bilge N.:
Hyperfractionated Radiotherapy (H-RT) and Concomitant Continuous Infusion (CCI) Epirubicin in Locally Advanced Soft Tissue Sarcomas       (STS)
Twenty-Ninth Annual Meeting, Orlando, Proc Am Soc Clin Onco, 12:     471, 1993.
  • Topuz E., Aydıner A., Öztürk N., Kardaş H.:
Intraperitoneal Chemotherapy (IPC) in Primary and Refractory Ovarian  Carcinoma
Proc Am Soc Clin Onco, 12: 273, 1993.
  • Aydıner A., Topuz E., Kardaş H., Öztürk N., Kizir A., Oral E.N.:
Local Complications of Intraperitoneal Chemotherapies Performed with “Single-Use” Catheters.
Fourth International Congress On Anti-Cancer Chemotherapy.
France. Abstract book, p.200, 1993.
  • Topuz E., Aydıner A., Kizir A., Öztürk N., Kardaş H.:
Intraperitoneal Chemotherapy For Gastrointestinal Malignancies With Liver Metastasis And Hepatocellular Carcinomas.
Fourth International Congress On Anti-Cancer Chemotherapy, France. Abstract book, p.161, 1993
  • Aydıner A., Yasasever V., Topuz E., Dişçi R., Aslay I., Öztürk N.,
Dinçol K., Bilge N.:
Analysis of Serum Tumor Merkers for Diagnosis of Skeletal          Metastases.
ECCO (7), Israel. European J Cancer (supplement) 29: 249, 1993.
  • İnanç SE., Onat H., Aydıner A., Altun M., Oral E.N., Bilge N.,Topuz E.:
Cisplatin, Fluorouracil and alpha-interferon for recurrent or metastatic head and neck cancer.
XVI.International Cancer Congress, İndia, Abstract book: pSHN6-11      1994.
  • Topuz E., Aydıner A., Saip P., İnanç S., Aslay I., Aykan F., Onat H.:
Intraperitoneal Chemotherapy (IPC) In Patients With Primary Ovarian Ca.
American Society of Clinical Oncology Thirtieth Annual Meeting,
Dallas, Proc Am Soc Clin Onco, 13: 270, 1994.
  • Onat H., İnanç S.E., Pişkin S., Ekmekçioğlu S., Arıcı A., Topuz E.:
Myeloprotective Effect of GM-CSF Administered Prior to Chemotherapy (CT).
American Society of Clinical Oncology Thirtieth Annual Meeting,
Dallas, Proc Am Soc Clin Onco, 13: 270, 1994.
  • Aykan N.F., Aydıner A., Ertürk N., Onat H., Topuz E, Dinçer M.,
Karadeniz A., Bilge N.:
The Prognostic Value of the Adjuvant Chemothearpy Timing and dose    Intensity in Early Breast Cancer.
9th Mediterranean Congress of Chemotherapy, Milano. Abstract book,      p.95, 1994.
  • Topuz E., Aydıner A., Saip P., Bengisu E., Dinçer M., Topuzlu C.:
Diagnostic Efficiency of Computerised Tomography (CT) and Serum Ca-125 Levels After Intraperitoneal Chemotherapies (IPC) In Patients With Ovarian Carcinoma.
First Educational Convention, Paris. European J Cancer (sup.1) 30: 43, 1994.
  • Aydıner A., Saip P., Topuz E., Dişçi R., Dinçol K., Onat H.:
Risk Factors Influencing Emesis for Patients Undergoing Cisplatin-Based Chemotherapy.
19th ESMO Congress, Lisbon. Annals of Oncology (supplement) 5: 290-210, 1994.
  • Topuz E., Aydıner A., Saip P., Aykan F., Onat H., Karadeniz A.:
A Phase II Trial of Divided Epirubicin Dosages in Combination Therapies with GM-CSF for Small Cell Lung Cancer (SCLC).
19th ESMO Congress, Lisbon.Annals of Oncology (supplement) 5:167-    168, 1994.
  • Onat H., İnanç S.E., Saip P., Topuz E.:
Tropisetron in the Prevention of Emesis Associated with Multiple-Day Cisplatin-Based Chemotherapy .
Fifth International Congress On Anti-Cancer Chemotherapy. Paris. Abstract book: 230, 1995.
  • İnanç S.E., Onat H., Oğuz H., Topuz E.:
Autoimmune Phenomena in Patients Receiving Alpha-Interferon Therapy.
Fifth International Congress On Anti-Cancer Chemotherapy. Paris, Abstract book: 230, 1995.
  • Topuz E., Saip P., Aydıner A., İnanç S.E., Onat H., Aykan F.:
Phase II Study of Cisplatinum, Fluorourasil and Calcium Folinate Combination in Antracycline Rezistant Metastatic Breast Cancer.
Fifth International Congress On Anti-Cancer Treatment, Paris. Abstract book: 230, p.541,1995.
  • Aydıner A., Saip P., Topuz E., Dinçol K., Dişçi R.:
Beta 2-Microglobulin in Lung Cancer.
Fifth International Congress On Anti-Cancer Treatment, Paris. Abstract book. p.543,1995.
  • Onat H., İnanç S.E., Saip P., Topuz E.:
Interferon Alpha-2b In Advanced Renal Cell Ca.
19th International Congress of Chemotherapy. Montreal, Can.J.Infect.Dis.6: supp.C 316, 1995.
  • Saip P., Onat H., İnanç S., Topuz E.:
Ondansetron and domperidon in patients receiving 3 courses of FEC for breast Ca. Supportive Care in Cancer. 3:5, p.345 Sept.1995.
  • Aydıner A., Buğra Z., Topuz E., Meriç M.:
Acute Myocardial Infarction in Man Treated with Epirubicin for Non- Hodgkin Lymphoma
American Journal of Clinical Oncology, 18(5): 444-448, 1995.
  • Topuz E., Salepçi T., Aydıner A., Saip P., İnanç S.E., Karadeniz A.,       Aykan F.:
“Oral Etoposide in Small Cell Lung Cancer”.
Sixth International Congress, On Anti-Cancer Treatment, Paris. Abstract
book, p.199, 1996.
  • Aydıner A., Aytekin Y., Topuz E.:
“Effect of Cisplatin On Testis Tissue And Leydig Cell-Pituitary Axis”.
Sixth International Congress, On Anti-Cancer Treatment, Paris. Abstract
book, p.225, 1996.
  • Topuz E., Aydıner A., Saip P., Salepçi T., Bengisu E., Berkman S.:
Salvage Intraperitoneal Chemotherapy With Cisplatin and Mitoxantron
for Ovarian Cancer.
Proceedings, American Society of Clinical Oncology, Thirty-Second Annual Meeting, Philadelphia. Abstract book, 292, 1996.
  • İnanç S.E., Onat H., Adalet K., Yasasever V., Karaloğlu D., Dalay N.,
Topuz E.:
Fluorouracil (FU) Cardiotoxicity (CDT) and Coagulation Parameters.
Program/Proceedings, American Society of Clinical Oncology, Thirty-     Second Annual Meeting, Philadelphia. Abstract book, 537, 1996.
  • Topuz E., Saip P., Aydıner A., Taş F., Bengisu E.:
Intraperitoneal (IP) and intravenous (IV) Chemotherapy Combination in
Patients (PTS) with Primary Ovarian.
Annals of Oncology, 21st Congress of the European Society for Medical
Oncology, Abstracts, 7: supp.5, p.77, 1996.
  • Taş F., Aykan N.F., Aydıner A., Dişçi R., Demir C., Topuz E.:
Risk Factors for Mucositis in Patients (Pts) with Colorectal Cancer           Treated
with Standart 5-FU Based Regimen.
Annals of Oncology, 21st Congress of the European Society for    Medical
Oncology, Abstracts, 7: supp.5, p.40, 1996.
  • Aydıner A., Taş F., Kizir A., Karadeniz A., Topuz E., Yasasever V.,       Dişçi R.:
Utility of the Serum Tumor Markers: CYFRA 21.1, CEA, and SCC in Squamous Cell Lung Cancer (SqCLC).
Annals of Oncology, 21st Congress of the European Society for    Medical
Oncology, Abstracts, 7: supp.5, p.103, 1996.
  • Fırat D., İçli F., Topuz E., Berk O., Barışta I., Danel P., Le Pape I., Delgado    F.M.:
Navelbine (NVB)+Cisplatin (CDDP) 20 Mg/m2 /5 Days in Inoperable Stage III & Stage IV Non Small Cell Lung Cancer: Multicentre Study.
Annals of Oncology, 21st Congress of the European Society for    Medical
Oncology, Abstracts, 7: supp.5, p.103, 1996.
  • Onat H., İnanç S., Saip P., Topuz E.:
Prevention of chemotherapy- induced emesis in patients with germ cell tumors receiving multiple-day cisplatin-based chemotherapy: effiacy and tolerability of tropisetron.
Turkish Journal of Cancer, 26: 4: 1996.
  • Saip P., Aydıner A., Topuz E.:
An Anti-Ri Positive Paraneoplastic Syndrome Associated With Ovarian  Carcinoma
Seventh International Congress On Anti-Cancer Treatment, Abstracts,     Palais Des Congrés, Paris-France. p. 160, February 3rd-6th, 1997.
  • Taş F., Aydıner A., Karadeniz A., Topuz E.:
Utility of Serum Tumor Markers Carcinoembryonic Antigen (CEA) and  Beta 2-Microglobulin (( 2-MG) in Patients with Lung Cancer.
Seventh International Congress On Anti-Cancer Treatment, Abstracts, Palais Des Congrés, Paris-France. p. 232, February 3rd-6th, 1997.
  • Topuz E., Aydıner A., Saip P., Aydın T., Salihoğlu Y., Topuzlu C.:
Local complications with intraperitoneal chemotherapy.
American Society of Clinical Oncology, Thirty-Third Annual Meeting
May 17-20, 1997, Denver, CO. Proceedings of ASCO Vol:16, 379a 1997.
  • Topuz E., Saip P., Demir C., Aykan F., Aydıner A:
Adjuvant intraperitoneal cisplatin, mitoxantrone, fluorouracil and calcium folinate combination in gastric patients.
American Society of Clinical Oncology, Thirty-Third Annual Meeting
May 17-20, 1997, Denver, CO. Proceedings of ASCO Vol:16, 308a, 1997
  • Saip P., Başaran M., Aydıner A., Erdoğan O., Salepçi T., Taş F., Topuz E.: ECG and blood pressure changes during the 6-hours paclitaxel infusion.
ECCO 9.The European Cancer Conference. EJC, 33:8: p.56 , 1997.
  • Berrak E., Aslay I., Öztürk N., Dinçer M., Aydıner A., Özbilen S., Dişçi R.,
Saip P., Topuz E., Töre G.:
The effects of different treatment models on Turkish women with uterine sarcoma.
ECCO 9.The European Cancer Conference. EJC, 33:8: p.209 , 1997.
  • Topuz E., Taş F., Aydıner A., Demir C., Saip P., Salepçi T., Karadeniz A.,
Ertürk N.:
Oral Etoposide in patients with small cell lung cancer.
ECCO 9.The European Cancer Conference. EJC, 33:8: p.237 , 1997.
  • Aydıner A., Taş F., Saip P., Karadeniz A., Demir C., Salepçi T., Topuz E.:
Oral etoposide in patients (pts) with Kaposi’s sarcoma (KS).
ECCO 9.The European Cancer Conference. EJC, 33:8: p.260 , 1997.
  • Saip P, Tenekeci N, Demir C, Aydıner A, Dinçer M, İnanç S, Topuz E:
The Response Evaluation of Bone Metastases (BM) in Breast Cancer: Value of Magnetic Resonance Imaging (MRI). Proceedings of ASCO. 17: p.172a Abstract Book (663), 1998.
  • Topuz E, Aydıner A, Saip P, Taş F, Demir C, Şakar B, Dişçi R.:
The Diagnostic Efficiencies of Serum Ca 125 Level and Abdominal Computerized Tomography (CT) After Intraperitoneal Chemotherapy (IPC) in Patients With Epithelial Ovarian Cancer. Proceedings of ASCO. 17: p.364a Abstract Book (1406A), 1998.
  • Aydıner A, Karadeniz A, Uygun K, Taş Ş, Taş F, Saip P, Demir C, Dişçi R,
Topuz E.: Second Primary Lung Cancers: Differences Between Metachronous and Synchronous Tumors. Proceedings of ASCO. 17: p.477a Abstract Book (1835), 1998.
  • Saip P, Onat H, Başaran M, Taş F, Demir C, Uygun K, Topuz E.:
Clinical efficacy of diazepam in prophylaxis of acute and delayed emesis induced by cisplatin based chemotherapy. A prospective randomised trial.
23rdCongress of the European Society for Medical Oncology (ESMO).
Annals of Oncology, Abstracts Book, 9: 4: p.146, (701P), 1998.
  • Topuz E, Saip P, Aydıner A, Salihoğlu Y, Yılmaz T, Topuzlu C.:
Catheter complications associated with intraperitoneal chemotherapy.
Eur J Gynaec Oncol 19: 3: 275-279, 1998.
  • A. Aydıner, H. Koyuncu, E. Topuz, R. Dişçi.
Clinical pharmacokinetic comparative crossover study between three times a day once a day-oral administration of etoposide
ECHO 10 The Europen Cancer Confarence, 12-16 September 1999 Vienna
  • E. Topuz, A. Aydıner, Z. Durna.
Nursing responsibilities in clinical trials in the Istanbul Universty Oncology Institute and the implementation of education programmes
ECHO 10 The Europen Cancer Confarence, 12-16 September 1999 Vienna
  • E. Topuz, F.N Aykan M. Başaran, K. Uygun, F. Taş, B. Şakar, P. Saip,
D. Buğra, H. Camlıca, A. Aydiner.
Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil and calcium folinate in stage II-III gastric cancer
ECHO 10 The Europen Cancer Confarence, 12-16 September 1999 Vienna
  • A. Aydıner, A. Karadeniz, F. Yaman, K. Uygun, F. Taş, R. Dişçi, E. Topuz.
Risk factors of for the Development of Second Primary Cancer (SPC) in Upper- Aerrodigestive Cancer (UADC).
American Society of Clinical Oncology. Ttirty-Sixth Annual Meeting May 20-23, 2000
  • Aydıner A., Topuz E., Eralp Y., Taş F., Saip P.
A case with multiple pulmonary nodules and renal vasculitis.
ICOACT 10th Internatıonal Congress on Antı-Cancer Treatment.From January 31st to February 3rd 2000 Palais des Congres Paris-France
  • Saip P., Uygun K., Topuz E., Başaran M., Taş F., Aydıner A., Aslay I., Dinçer M.
Long term results and prognostic factors of granulosa cell tumors of the ovary.
Annals of Oncology, Supplement 4 to Volume 11,2000. Abstract Book of the 25 th ESMO Congress, Hamburg, Germany, 13-17 October 2000.
  • Topuz E., Eralp Y., Aydıner A., Saip P., Taş F., Yavuz E., Salihoğlu Y.
The role of chemotherapy in malignant mixed mullerian tumors of the female genital tract.
Annals of Oncology, Supplement 4 to Volume 11,2000. Abstract Book of the 25 th ESMO Congress, Hamburg, Germany, 13-17 October 2000.
  • Aydıner A., Topuz E., Argon A., Saip P., Taş F., Eralp Y., Kardaş H.
Chemotherapy in advanced breast carcinoma: Efficacy of primary and secondary or tertiary docetaxel use.
Annals of Oncology, Supplement 4 to Volume 11,2000. Abstract Book of the 25 th ESMO Congress, Hamburg, Germany, 13-17 October 2000.
  • E. Topuz, A. Aydıner, P. Saip, Y. Eralp, F. Taş, Salihoğlu Y, N. Tenekeci.
Correlation of CA 125 Levels and Computerized Tomography Imaging with Laparotomic Findings Following Intraperitoneal Chemotherapy in Patients with Ovarian Cancer.
American Society of Clinical Oncology. Ttirty-Sixth Annual Meeting May 20-23, 2000
  • Aydıner A., Topuz E., Eralp Y., Taş F., Saip P.
A case with multiple pulmonary nodules and renal vasculitis.
ICOACT 10th International Congress on Antı-Cancer Treatment. From January 31st to February 3rd 2000 Palais des Congress Paris-France.
  • Topuz E., Eralp Y., Aydiner A., Saip P., Tas F.
Intraperitoneal chemotherapy in patients with peritoneal malignant mesothelioma.
Procedings of ASCO Vol 20, p2286, 2001.
  • Uygun K., Koçak Z., Saip P., Başaran M., Aydiner A., Dinçer M., Tas F., Topuz E.
Recurrent granulosa cell tumor of the ovary: retrospective analysis.
ECCO 11 the European Cancer Confarence Vol 37 Supp 6 October 2001.
  • Topuz E., Aydiner A., Eralp Y., Saip P., Tas F., Salihoğlu Y., Berkman S., Bengisu E.
Efficacy of paclitaxel in combination with intraperitoneal cisplatinum in patients with advanced ovarian cancer.
ECCO 11 the European Cancer Confarence Vol 37 Supp 6 October 2001.
  • Eralp Y., Aydiner A., Toptani S., Tas F., Camlica H., Topuz E.
Circulating HER-2/NEU levels in patients with melanoma.
EORTC Molecular Targets and Cancer Therapeutics. Discovery, Biology, and Clinical Applications October 29 – November 2, 2001.
  • B. Sakar, M. Basaran, A. Argon, S. Alici, Y. Eralp, E. KAytan, D. Buğra, F.N. Aykan,
E.Topuz.
The Link between local recurrence and survival in patients with primary rectal cancer.
American Society of Clinical Oncology My 18-21, 2002.
  • E. Topuz, P. SAip, A. Aydıner, Y. Eralp, S. Tuzlalı, S. Berkman.
Intraperitoneal cisplatinum as consolidation treatment for ovarian carcinoma at   . ..   .                   .           pathologic
complete remission following primary platinum-based chemotherapy.
American Society of Clinical Oncology My 18-21, 2002.
  • E. Topuz, E. Kaytan, P. Saip, Y. Eralp, K. Sönmezoğlu, a. Aydıner.
Comparative evaluation of diagnosing recurrent ovarian carcinoma with CA 125, PET and CT.
American Society of Clinical Oncology May 31-June 3,2003.
  • A. Aydıner, E. Topuz, E. N. Oral, E. Kaytan, H. Karagöl, Y. Eralp, A. Kizir.
Concominant chemoradiotherapy in locally advanced non-small cell lung cancer: A . ..    .           phase II clinical trial.
American Society of Clinical Oncology May 31-June 3,2003.
  • P. Saip, S. Tuzlalı, K. Demir, B. Şakar, E. Yavuz, S. Berkman, E. Bengisu, E. Topuz.
Value of glutathion-s transferase pi ( GST pi) as a prognostic factor in epithelial ovarian     .           carcinoma.
American Society of Clinical Oncology May 31-June 3,2003.
  • Topuz E, Tas F, Argon A, Duranyıldız D, Oguz H, Yasasever V, Eralp Y, Aydıner A.
Serum levels of leptin and proinflammatory cytokines in advanced stage non-small cell
Lung cancer.      Proceedings of ASCO, Abstr 2594, 2005
KİTAPLARINDAN BAZILARI
  • Akciğer Kanserleri (Biyoloji, Tanı, Evreleme, Tedavi)- Editör: E.Topuz
İstanbul Üniversitesi Onkoloji Enstitüsü Yayınları (1).
Küçük Hücreli Dışı Akciğer Kanseri Kemoterapisi. S.112-123, (E.Topuz)
  • Over Kanseri (Biyoloji, Tanı, Evreleme, Tedavi)- Editör: E.Topuz
İstanbul Üniversitesi Onkoloji Enstitüsü Yayınları (2). 1996
İntraperitoneal (İP) Kemoterapi. S.157-173, (E.Topuz).
  1. Kemoterapiye Bağlı Belirtilerin Denetimi ve Bakımı - Editör: E.Topuz,
H.Onat
Bilimsel ve Teknik Yayınları Çeviri Vakfı, 1996.
  • Klinik Onkoloji Temel İlkeler ve Hemşirelik Bakımı - Editör: E.Topuz,
Doç.Dr. Adnan Aydıner, Bilimsel ve Teknik Yayınları Çeviri Vakfı.
İstanbul Üniversitesi Onkoloji Enstitüsü Yayınları (4): 1997.
  • Meme Kanseri (Biyoloji, Tanı, Evreleme, Tedavi) - Editör: E.Topuz.,
İstanbul Üniv. Onkoloji Enstitüsü Yayınları (3): 1997.
Meme Kanserinde Adjuvan İlaç Tedavisi. S.361-384. (A.Aydıner, E.Topuz).
Meme Kanserinde Primer Kemoterapi. S.384-398. (E.Topuz, A.Aydıner)
Lokorejyonal Rekürren Meme Kanserinde İlaç Tedavisi S.436-443. (A.Aydıner, E.Topuz).
  • Sindirim Sistemi Kanserleri (Biyoloji, Patoloji, Tanı, Tedavi).
Editörler: E.Topuz, N.Faruk Aykan.
İstanbul Üniv. Onkoloji Enstitüsü Yayınları (5): 1998.
Sindirim Sistemi Kanserlerinde Epidemiyoloji. S:3-12 (E.Topuz, C.Demir)
Mide Kanseri Tedavisinde Kemoterapi. S:230-243 (E.Topuz, T.Salepçi,
A.Aydıner)
Rejyonel Kemoterapi. S: 505-525 (E.Topuz, P.Saip)
  • Klinik Onkoloji. Editörler: E.Topuz, A. Aydıner, A.N. Karadeniz.
İstanbul Üniversitesi Onkoloji Enstitüsü Yayınları(6):2000-11-23
Meme Kanseri. S: 70-81 (A. Aydıner, M. Dinçer, E. Topuz)
Akciğer Kanseri. S: 82-89 (E. Topuz, A. Aydıner)
Jinekolojik Tümörler II. S: 287-291 (E.Topuz, P. Saip, Y. Salihoğlu)
Intrakaviter ve bölgesel Tedaviler. S. 292-299 ( E. Topuz, P. Saip )
  • Topuz E., Tas F.
Paraneoplastik sendromlar.
Kanser hastasına yaklaşım; tanı.tedavi ve takipte sorunlar. Editörler: Onat H, ve Mandel NM.
Nobel Tıp Kitabevleri. İstanbul, 2002, sayfa: 77-85.
  • Meme Kanseri Kitabı.
Prof. Dr. Erkan Topuz, Prof. Dr.Adnan Aydıner, Prof. Dr. Maktav Dinçer. 2003.
  • Metastatik Meme Kanserinde Sistemik Tedavi.
Prof. Dr. Erkan Topuz, Prof. Dr. Kazım Uygun, Prof. Dr. Adnan Aydıner (kitap bölümü)
Meme Kanseri Kitabı.
  • Lokal İleri Meme Kanserinde Sistemik Tedavi.
Prof. Dr. Erkan Topuz, Prof. Dr. Adnan Aydıner
Meme Kanseri Kitabı.
  • Meme, Gastrointestinal Sistem, Akciğer Kanserlerinde Tanı-Tedavi-Takip, Konsensus Kitabı.
Adnan Aydıner, Prof. Dr. Erkan Topuz
Antalya.2003.
  • 1. Ulusal Torasik Onkoloji Kongresi.
7-10 Ekim 2004. Antalya
  • Topuz E.
Kanserde Alternatif ve Tamamlayıcı Tıp. İletişim Yayıncılık. 2005.
  • Ulusal Meme Kanseri Konsensus Kitabı. 15-19 Kasım 2006 Bodrum. Prof. Dr. Adnan
Aydıner, Prof. Dr. Erkan Topuz
  • Onkoloji El Kitabı.
Prof. Dr. Adnan Aydıner, Prof. Dr. Erkan Topuz
Turgut Yayıncılık. 2006
  • Kanserde Tamamlayıcı Tıp. Prof. Dr. Erkan Topuz. İstanbul Medikal Yayıncılık 2007.
  • Anjiogenez. Prof. Dr. Erkan Topuz.          2007.
  • Meme Kanseri. NCCN Onkoloji Klinik Uygulama Klavuzu. V.2.2008.
  • E-Bülten

  • Hava Durumu

  • Döviz

    1 $ = 2,18 TL
    1 € = 2,90 TL
    426995 Ziyaretçi